Tag:
addiction
Latest Headlines
Latest Headlines
Intellipharmaceutics raises $5M to adance tamper-resistant oxycodone
Canada's Intellipharmaceutics International ($IPCI), a specialist in controlled-release drug formulations, is raising $5 million to fuel anticipated U.S. clinical trials for Rexista, a patented version of the highly addictive pain killer oxycodone designed to resist abuse.
New target could be key to beating back methamphetamine addiction
As bad as cocaine addiction can be for many, methamphetamine addiction can take hold even more quickly and ruin a patient's health in horrible ways. The heart, the aging process and even sperm
Search is on for new anti-addiction drug targets
A new generation of researchers is actively pursuing novel drug targets for an as-yet elusive pill to turn off addictions to food or cocaine, Discover Magazine reports. Their goal: To reduce levels
Scripps scientist devotes himself to finding the perfect addiction vax
To hear Scripps' Kim Janda tell the story, the science behind the quest for a new vaccine to fight addiction is so simple even a child could understand. But like many scientific quests in biopharma,
Pioneering Scripps scientist devotes a lifetime to addiction vaccines
To hear Scripps' Kim Janda tell the story, the science behind the quest for a new vaccine to fight addiction is so simple even a child could understand. But like many scientific quests in biopharma,
MonoSol, KemPharm partner on second ADHD thin-film drug
Those who suffer from attention deficit hyperactivity disorder (ADHD) are usually prescribed stimulants, or amphetamines, to help them focus. But this focus comes at a price. The drugs can be
Genes reveal gender differences in alcoholism onset
New research into differences between men and women in how the body handles alcohol could lead to more-targeted treatments for alcoholism that takes both genes and gender into account, according to a
Embera adds $4.5 million in Series A cash
Embera NeuroTherapeutics says it has garnered $4.5 million in a continuation of its Series A financing. The money will go to development of new treatments for smoking cessation and other addictions.
Addiction recognized as medical condition, not lack of willpower
Society, and science, are moving beyond the notion that addiction is primarily a moral or psychological problem--or simply a lack of willpower--and are recognizing it as a physical disease that can
Nabi shares in meltdown after NicVAX flunks Ph3
Shares of Nabi Biopharmaceuticals ( $NABI ) went into a meltdown this morning after the developer announced that the first of two late-stage studies for its experimental nicotine addiction vaccine
